Anti-angiogenic therapy for persistent, recurrent and metastatic cervical cancer-Reference-Cited by-同舟云学术

Anti-angiogenic therapy for persistent, recurrent and metastatic cervical cancer

Published:2019-05-29 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chuai Yunhai¹²,Wang Aiming¹²,Li Ying¹³,Dai Guanghai¹³,Zhang Xia¹³

Affiliation:

1. Chinese PLA General Hospital, Medical School of Chinese PLA; Fuxing Road No. 28 Beijing China 100853

2. Sixth Medical Center, Chinese PLA General Hospital; Department of Obstetrics and Gynaecology; Fucheng Road, No.6 Beijing China 100048

3. First Medical Center, Chinese PLA General Hospital; Department of Oncology; Fuxing Road No.28 Beijing China 100853

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013348/epdf/full

Reference46 articles.

1. Clinical trials of antiangiogenesis therapy in recurrent/persistent and metastatic cervical cancer;Alldredge;Oncologist,2016

2. Full prescribing information for Avastin (bevacizumab) injection https://www.gene.com/download/pdf/avastin_prescribing.pdf

3. Cancer of the cervix uteri;Bhatla;International Journal of Gynaecology and Obstetrics,2018

4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: A Cancer Journal for Clinicians,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Investigational Drug’s Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects;Cancer Investigation;2024-07-05